HomeEmerade® auto-injector recall

Emerade® auto-injector recall

May 5, 2023

Bausch Health, Canada Inc. has initiated a recall of their Emerade® 0.3 mg and 0.5 mg auto-injector devices in Canada due to a potential risk that the auto-injector may fail to activate or activate prematurely if dropped.

 Please read Health Canada’s advisory notice for more information.

What you should do if you have an Emerade auto-injector:  

  • Bring your in-date (not expired) Emerade auto-injector(s) to your pharmacist to get a replacement device as soon as possible. EpiPen® and ALLERJECT® auto-injectors remain available. To determine which device is best for you, please speak with your healthcare provider.  
  • You can bring a copy of Health Canada’s advisory notice to show the pharmacist. 
  • Health Canada has advised to keep your Emerade auto-injector until a replacement is obtained. 
  • Please share this information with your child’s school and let them know that any Emerade devices on school premises will need to be replaced with either EpiPen or ALLERJECT.  
  • As always, continue to follow and review our safety tips for managing food allergy and preventing reactions. 

For further information or questions, please contact Bausch Health, Canada Inc. directly at 1 800 361-4261.  

This message is a part of our Allergy Alerts service.

You can count on our Allergy Alerts service to ensure you are kept informed on safety issues that impact you.

Allergy Alerts logo

When a food or product is recalled, you want to know right away. By signing up for our Allergy Alerts service and emails, you’ll receive updates like these right at your fingertips – not to mention other essential allergy-related information and updates.

Tags: , ,